YoungWomen: Breast Cancer in Young Women: Is it Different?
Study Details
Study Description
Brief Summary
Breast cancer is the leading cancer among women in Saudi Arabia representing almost the third of cancer diagnosed in Saudi women. Breast cancer in Saudi women is more frequently observed at young age. The data on this observation is either lacking or scares. Furthermore, the pathological and molecular features of breast cancer in young women are not clear. The study will provide important information to the national health care planner about this disease in young women including shedding light on possible genetic risk factors
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
The study is a prospective longitudinal cohort study of young women with breast cancer. Over a 3-year period, we aim to identify a total of 600 women with newly diagnosed breast cancer, of those 300 women age 40 and younger and 300 older women from academic and community health care institutions across the Riyadh area. It is anticipated at least 400 of these women will agree to participate in the study. The comparable control group of older patients with breast cancer will be used for study comparison. Patient surveys, medical record review, and blood and tissue collection will be utilized. Women will be surveyed every 6 months after diagnosis. The study will investigate short and long-term disease and treatment issues, and psychosocial concerns. We will also collect tumor and blood samples to characterize the pathological and molecular aspects of tumors, and establish tumor bank for future studies.
Study Design
Outcome Measures
Primary Outcome Measures
- experience of breast cancer in young women [10 years]
To identify a cohort of young women (age 40 or younger) newly diagnosed with breast cancer in King Abdulaziz Medical City and other collaborating hospitals to assess a broad range of variables at baseline and over the course.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Female
-
Diagnosis of breast cancer
-
Age 40 or younger at diagnosis for study group and older women for control group
-
Informed consent obtained from patient
Exclusion Criteria:
- Absence of informed consent
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | King Abdul Aziz Medical City for National Guard Health Affairs | Riyadh | Saudi Arabia | 11426 |
Sponsors and Collaborators
- National Guard Health Affairs
Investigators
- Principal Investigator: Omalkahir Abulkhair, MD, King Abdul Aziz Medical City for National Guard
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- RC08/117